New Research on Inflammatory Breast Cancer

Recently, Emanuel Petriocoin and Lance Liotta of George Mason University’s (GMU) Center for Applied Proteomics & Molecular Medicine (CAPMM) discovered that activation of the protein ALK (anaplastic lymphoma kinase) is associated with inflammatory breast cancer, a particularly aggressive form of the disease: “Mason Research Gives Hope to Women With Deadliest Breast Cancer”.

Although this study was not funded by The Side-Out Foundation, Side-Out is incredibly proud to be associated with CAPMM through research in related clinical trials for breast cancer (see the Side-Out Protocol and I-SPY 2). The findings of the inflammatory breast cancer study may be put to use in the second phase of the Side-Out Protocol.

Related Stories

© The Side-Out Foundation is a 501(c)(3) non-profit organization. EIN 20-2510044
Dig Pink® is a registered trademark of the Side-Out Foundation